These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 18502707
1. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease. Fujiwaki T, Tasaka M, Yamaguchi S. J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul 15; 870(2):170-6. PubMed ID: 18502707 [Abstract] [Full Text] [Related]
2. Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. Fujiwaki T, Tasaka M, Takahashi N, Kobayashi H, Murakami Y, Shimada T, Yamaguchi S. J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb 17; 832(1):97-102. PubMed ID: 16431168 [Abstract] [Full Text] [Related]
3. Evaluation of sphingolipids in vitreous bodies from a patient with Gaucher disease, using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Fujiwaki T, Yamaguchi S, Tasaka M, Takayanagi M, Isobe M, Taketomi T. J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun 25; 806(1):47-51. PubMed ID: 15149610 [Abstract] [Full Text] [Related]
4. Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in tissues from sphingolipidosis patients. Fujiwaki T, Yamaguchi S, Sukegawa K, Taketomi T. J Chromatogr B Biomed Sci Appl; 1999 Aug 06; 731(1):45-52. PubMed ID: 10491988 [Abstract] [Full Text] [Related]
5. Application of delayed extraction-matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in pericardial fluid, peritoneal fluid and serum from Gaucher disease patients. Fujiwaki T, Yamaguchi S, Tasaka M, Sakura N, Taketomi T. J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug 25; 776(1):115-23. PubMed ID: 12127332 [Abstract] [Full Text] [Related]
6. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease. He X, Chen F, Gatt S, Schuchman EH. Anal Biochem; 2001 Jun 15; 293(2):204-11. PubMed ID: 11399033 [Abstract] [Full Text] [Related]
7. High-spatial resolution matrix-assisted laser desorption ionization imaging analysis of glucosylceramide in spleen sections from a mouse model of Gaucher disease. Snel MF, Fuller M. Anal Chem; 2010 May 01; 82(9):3664-70. PubMed ID: 20384358 [Abstract] [Full Text] [Related]
8. Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in cultured skin fibroblasts from sphingolipidosis patients. Fujiwaki T, Yamaguchi S, Sukegawa K, Taketomi T. Brain Dev; 2002 Apr 01; 24(3):170-3. PubMed ID: 11934514 [Abstract] [Full Text] [Related]
9. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Vanier MT. Biochim Biophys Acta; 1983 Jan 07; 750(1):178-84. PubMed ID: 6824712 [Abstract] [Full Text] [Related]
10. Glycoprotein storage in Gaucher disease: lectin histochemistry and biochemical studies. DeGasperi R, Alroy J, Richard R, Goyal V, Orgad U, Lee RE, Warren CD. Lab Invest; 1990 Sep 07; 63(3):385-92. PubMed ID: 2395332 [Abstract] [Full Text] [Related]
11. A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. Sugiyama E, Hara A, Uemura K. Anal Biochem; 1999 Oct 01; 274(1):90-7. PubMed ID: 10527500 [Abstract] [Full Text] [Related]
13. Sphingomyelin storage in a patient with myoclonus epilepsy as a main clinical symptom -- a varient in Niemann-Pick disease type C. Kunishita T, Taketomi T. Jpn J Exp Med; 1979 Apr 01; 49(2):151-6. PubMed ID: 113605 [Abstract] [Full Text] [Related]
17. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Sullards MC. Methods Enzymol; 2000 Apr 01; 312():32-45. PubMed ID: 11070861 [Abstract] [Full Text] [Related]
18. Phosphatidylcholine removal from brain lipid extracts expands lipid detection and enhances phosphoinositide quantification by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Johanson RA, Buccafusca R, Quong JN, Shaw MA, Berry GT. Anal Biochem; 2007 Mar 15; 362(2):155-67. PubMed ID: 17266916 [Abstract] [Full Text] [Related]
19. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease. Gal AE, Brady RO, Hibbert SR, Pentchev PG. N Engl J Med; 1975 Sep 25; 293(13):632-6. PubMed ID: 239343 [Abstract] [Full Text] [Related]
20. Matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis of glycosphingolipids including gangliosides. Taketomi T, Hara A, Uemura K, Sugiyama E. Acta Biochim Pol; 1998 Sep 25; 45(4):987-99. PubMed ID: 10397345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]